Clinical Reporting Form Updates
Covid 19 form
The Covid-19 form was introduced for participants who had been admitted to the hospital for treatment of COVID-19. We have not received any new forms since our last update (total number of forms 109). For each form completed, 50 euros will be reimbursed for next year of submission.
You can read more about the form in the COVID-19 eCRF Manual of Operations here.
Cabotegravir
In 2021, EuroSIDA started to collect detailed data on participants who receive treatment with injectable long-acting cabotegravir and/or long-acting rilpivirine. Data are collected annually in two separate REDCap forms. The sub-study will run for five years. We have not received any new participants initiating the treatment since our last update (total number of forms 13).
MISTRAL study
The MISTRAL study has reached the process of finalizing the data processing agreements (DPAs) and site agreements with sites. We are pleased that we have received ethics approvals from half of the 25 EuroSIDA sites that are participating in MISTRAL. As we are close to finalizing contracts and DPAs with many sites, we are equipped to initiate the study and expect to enroll participants from one to three sites during the summer.
For more information on the MISTRAL study click here.
|